Milestone Scientific (NYSE:MLSS) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Friday morning. The brokerage issued a hold rating on the stock.

Separately, Benchmark began coverage on Milestone Scientific in a research note on Thursday, October 10th. They set a “speculative buy” rating and a $1.25 price objective for the company.

Milestone Scientific Stock Performance

Shares of MLSS opened at $0.79 on Friday. The stock has a 50-day moving average of $0.94 and a two-hundred day moving average of $0.82. The stock has a market cap of $61.17 million, a P/E ratio of -11.14 and a beta of 1.08. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10.

Milestone Scientific (NYSE:MLSS) last issued its earnings results on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). Milestone Scientific had a negative net margin of 54.87% and a negative return on equity of 60.78%. The firm had revenue of $1.85 million during the quarter.

Insider Buying and Selling

In other news, Director Leonard Osser sold 107,984 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the transaction, the director now directly owns 4,606,882 shares in the company, valued at $4,284,400.26. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Over the last three months, insiders have sold 251,106 shares of company stock worth $236,451. 24.75% of the stock is owned by insiders.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.